Cargando…

Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of gastrointestinal stromal tumors of dogs

BACKGROUND: Gastrointestinal stromal tumors (GISTs) are uncommon intestinal neoplasms in the dog. Literature regarding adjunctive therapy for GISTs in dogs is sparse. High‐risk GISTs in humans respond to tyrosine kinase inhibition in the adjuvant setting. OBJECTIVES: To review cases of toceranib pho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berger, Erika P., Johannes, Chad M., Jergens, Albert E., Allenspach, Karin, Powers, Barbara E., Du, Yingzhou, Mochel, Jonathan P., Fox, Leslie E., Musser, Margaret L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2018
Materias:	SMALL ANIMAL
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271363/ https://www.ncbi.nlm.nih.gov/pubmed/30307656 http://dx.doi.org/10.1111/jvim.15335

Ejemplares similares

Toceranib phosphate (Palladia) for the treatment of canine exocrine pancreatic adenocarcinoma
por: Musser, Margaret L., et al.
Publicado: (2021)

Effects of Toceranib Phosphate on Systolic Blood Pressure and Proteinuria in Dogs
por: Tjostheim, S.S., et al.
Publicado: (2016)

Effects of Toceranib Phosphate on the Hypothalamic‐Pituitary‐Thyroid Axis in Tumor‐Bearing Dogs
por: Hume, K.R., et al.
Publicado: (2017)

Effects of toceranib phosphate (Palladia) monotherapy on multidrug resistant lymphoma in dogs
por: YAMAZAKI, Hiroki, et al.
Publicado: (2017)

Assessment of postoperative adjuvant treatment using toceranib phosphate against adenocarcinoma in dogs
por: Yamazaki, Hiroki, et al.
Publicado: (2020)

Pulse‐Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs
por: Burton, J.H., et al.
Publicado: (2015)

Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of inoperable, metastatic, or recurrent canine pheochromocytomas: 5 dogs (2014–2017)
por: Musser, Margaret L., et al.
Publicado: (2018)

Interleukin‐13 and interleukin‐33 mRNA are underexpressed in the duodenal mucosa of German Shepherd dogs with chronic enteropathy
por: Kathrani, Aarti, et al.
Publicado: (2019)

Evaluation of toceranib for treatment of apocrine gland anal sac adenocarcinoma in dogs
por: Heaton, Caitlin M., et al.
Publicado: (2020)

Plasma cytokeratin‐18 concentrations as noninvasive biomarker of early gastrointestinal toxicosis in dogs receiving toceranib
por: Kovac, Rachel L., et al.
Publicado: (2018)

c‐Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine
por: Weishaar, K.M., et al.
Publicado: (2017)

Toceranib phosphate (Palladia) reverses type 1 diabetes by preserving islet function in mice
por: KISHI, Kazuhisa, et al.
Publicado: (2023)

Development of an in vitro model of acquired resistance to toceranib phosphate (Palladia®) in canine mast cell tumor
por: Halsey, Charles HC, et al.
Publicado: (2014)

Relationship of the mucosal microbiota to gastrointestinal inflammation and small cell intestinal lymphoma in cats
por: Garraway, Kayode, et al.
Publicado: (2018)

Narrative review of therapies for chronic enteropathies in dogs and cats
por: Makielski, Kelly, et al.
Publicado: (2018)

Feline restrictive orbital myofibroblastic sarcoma treated with toceranib phosphate (Palladia) as adjuvant chemotherapy: A case study of one cat
por: Komatsu, Hiroyuki, et al.
Publicado: (2023)

Bacterial Cholangitis, Cholecystitis, or both in Dogs
por: Tamborini, A., et al.
Publicado: (2016)

Evaluation of Serum 3‐Bromotyrosine Concentrations in Dogs with Steroid‐Responsive Diarrhea and Food‐Responsive Diarrhea
por: Sattasathuchana, P., et al.
Publicado: (2017)

Toxicity, outcome, and management of anthracycline overdoses in 16 dogs
por: Lawson, Haylie C., et al.
Publicado: (2021)

Retrospective evaluation of risk factors for development of kidney injury after parenteral furosemide treatment of left‐sided congestive heart failure in dogs
por: Giorgi, Maria E., et al.
Publicado: (2022)

Alterations in serum amino acid concentrations in dogs with protein‐losing enteropathy
por: Kathrani, Aarti, et al.
Publicado: (2018)

Apparent total tract digestibility, fecal characteristics, and blood parameters of healthy adult dogs fed high-fat diets
por: Kilburn, Logan R, et al.
Publicado: (2020)

Serologic and fecal markers to predict response to induction therapy in dogs with idiopathic inflammatory bowel disease
por: Otoni, Cristiane C., et al.
Publicado: (2018)

Retrospective evaluation of a dose‐dependent effect of angiotensin‐converting enzyme inhibitors on long‐term outcome in dogs with cardiac disease
por: Ward, Jessica L., et al.
Publicado: (2021)

Clinical utility of an immunoglobulin A‐based serological panel for the diagnosis of chronic enteropathy in dogs
por: Langlois, Daniel K., et al.
Publicado: (2023)

Calcium and phosphate homeostasis in dogs with newly diagnosed naturally occurring hypercortisolism
por: Corsini, Andrea, et al.
Publicado: (2021)

Ki‐67/CD3 ratio in the diagnosis of chronic inflammatory enteropathy in dogs
por: Karlovits, Sonja, et al.
Publicado: (2019)

Upregulation of signal transducer and activator of transcription 3 in dogs with chronic inflammatory enteropathies
por: Manz, Anita, et al.
Publicado: (2021)

A Multi-Institutional Retrospective Analysis of Toceranib Phosphate for Presumed or Confirmed Canine Aortic Body Chemodectomas
por: Coto, Giovanna M., et al.
Publicado: (2021)

Longitudinal assessment of microbial dysbiosis, fecal unconjugated bile acid concentrations, and disease activity in dogs with steroid‐responsive chronic inflammatory enteropathy
por: Guard, Blake C., et al.
Publicado: (2019)

Use of a Granulocyte Immunofluorescence Assay Designed for Humans for Detection of Antineutrophil Cytoplasmic Antibodies in Dogs with Chronic Enteropathies
por: Florey, J., et al.
Publicado: (2017)

Evaluation of novel serological markers and autoantibodies in dogs with inflammatory bowel disease
por: Estruch, Juan J., et al.
Publicado: (2020)

Pyogranulomatous Pancarditis with Intramyocardial Bartonella henselae San Antonio 2 (BhSA2) in a Dog
por: Donovan, T.A., et al.
Publicado: (2016)

Efficacy of telmisartan for the treatment of persistent renal proteinuria in dogs: A double‐masked, randomized clinical trial
por: Lourenço, Bianca N., et al.
Publicado: (2020)

Evaluation of the Cortisol‐to‐ACTH Ratio in Dogs with Hypoadrenocorticism, Dogs with Diseases Mimicking Hypoadrenocorticism and in Healthy Dogs
por: Boretti, F.S., et al.
Publicado: (2015)

Hypothermia in Uremic Dogs and Cats
por: Kabatchnick, E., et al.
Publicado: (2016)

Clinical Features and Outcome of Dogs with Epiglottic Retroversion With or Without Surgical Treatment: 24 Cases
por: Skerrett, S.C., et al.
Publicado: (2015)

Atrioventricular accessory pathways in 89 dogs: Clinical features and outcome after radiofrequency catheter ablation
por: Wright, Kathy N., et al.
Publicado: (2018)

Long‐term Outcome of Irish Wolfhound Dogs with Preclinical Cardiomyopathy, Atrial Fibrillation, or Both Treated with Pimobendan, Benazepril Hydrochloride, or Methyldigoxin Monotherapy
por: Vollmar, A.C., et al.
Publicado: (2016)

Advances in the diagnosis of acute pancreatitis in dogs
por: Cridge, Harry, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5re62jnur1l727n01dpvg1v0dc